The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-[(6-Methylthieno[2,3-d]pyrimidin-4-yl)amino]isophthalic acid ID: ALA3793637
Cas Number: 1081316-05-3
PubChem CID: 28383625
Max Phase: Preclinical
Molecular Formula: C15H11N3O4S
Molecular Weight: 329.34
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc2c(Nc3cc(C(=O)O)cc(C(=O)O)c3)ncnc2s1
Standard InChI: InChI=1S/C15H11N3O4S/c1-7-2-11-12(16-6-17-13(11)23-7)18-10-4-8(14(19)20)3-9(5-10)15(21)22/h2-6H,1H3,(H,19,20)(H,21,22)(H,16,17,18)
Standard InChI Key: YUTKKHOJCYZXAI-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
-1.0028 1.5132 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-0.9971 -3.0138 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.2935 -3.7700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2901 -5.2700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5873 -6.0231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.8881 -5.2761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.8917 -3.7761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5944 -3.0231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7889 0.0269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.1917 -3.0261 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.2305 -3.6268 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-6.1928 -1.8261 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.5868 -7.5239 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5472 -8.1232 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.6255 -8.1249 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
4 6 1 0
5 6 2 0
6 11 1 0
10 7 1 0
7 5 1 0
4 8 1 0
8 9 1 0
10 11 2 0
9 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 9 1 0
10 17 1 0
18 19 1 0
18 20 2 0
15 18 1 0
13 21 1 0
21 22 1 0
21 23 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 329.34Molecular Weight (Monoisotopic): 329.0470AlogP: 3.14#Rotatable Bonds: 4Polar Surface Area: 112.41Molecular Species: ACIDHBA: 6HBD: 3#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 4.25CX Basic pKa: 3.12CX LogP: 3.01CX LogD: -2.08Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.67Np Likeness Score: -1.42
References 1. Ostrynska OV, Balanda AO, Bdzhola VG, Golub AG, Kotey IM, Kukharenko OP, Gryshchenko AA, Briukhovetska NV, Yarmoluk SM.. (2016) Design and synthesis of novel protein kinase CK2 inhibitors on the base of 4-aminothieno[2,3-d]pyrimidines., 115 [PMID:27017545 ] [10.1016/j.ejmech.2016.03.004 ]